According to a study published in JAMA Internal Medicine this past week, artificial intelligence chatbot assistants can provide responses to patients’ health questions that are of comparable quality – and empathy – to those written by physicians.
A team of licensed healthcare…
Source: Healthcareitnews.com and Read More
FDA approves breast cancer drug
The FDA has approved Eli Lilly’s imlunestrant, an oral estrogen receptor antagonist, for the treatment of adults with estrogen receptor positive, HER2-negative, ESR1-mutated advanced or
